Article Versions Notes

Linder T, Papaplioura E, Ogurlu D, Geyrhofer S, Hummelbrunner S, Schachner D, Atanasov AG, Mihovilovic MD, Dirsch VM, Schnürch M. Investigation of Leoligin Derivatives as NF-κΒ Inhibitory Agents. Biomedicines. 2022; 10(1):62. https://doi.org/10.3390/biomedicines10010062

Linder, Thomas, Eleni Papaplioura, Diyana Ogurlu, Sophie Geyrhofer, Scarlet Hummelbrunner, Daniel Schachner, Atanas G. Atanasov, Marko D. Mihovilovic, Verena M. Dirsch, and Michael Schnürch. 2022. "Investigation of Leoligin Derivatives as NF-κΒ Inhibitory Agents" Biomedicines 10, no. 1: 62. https://doi.org/10.3390/biomedicines10010062

Linder, T., Papaplioura, E., Ogurlu, D., Geyrhofer, S., Hummelbrunner, S., Schachner, D., Atanasov, A. G., Mihovilovic, M. D., Dirsch, V. M., & Schnürch, M. (2022). Investigation of Leoligin Derivatives as NF-κΒ Inhibitory Agents. Biomedicines, 10(1), 62. https://doi.org/10.3390/biomedicines10010062